No Data
No Data
UBS Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $700
UBS analyst John Sourbeer maintains $Thermo Fisher Scientific(TMO.US)$ with a buy rating, and adjusts the target price from $650 to $700.According to TipRanks data, the analyst has a success rate of 2
Thermo Fisher Likely to Update Growth Plan, Focus on Business Lines, Services, UBS Says
Clinical Chemistry Analyzer Industry Research and Competitive Landscape 2024-2032 Featuring Thermo Fisher Scientific, Abbott Labs, Siemens Healthineers, Danaher, J&J, Sysmex ADR, HORIBA, and Hitachi - ResearchAndMarkets.com
Thermo Fisher Is Maintained at Buy by B of A Securities
Thermo Fisher Scientific Analyst Ratings
BofA Securities Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $675
BofA Securities analyst Michael Ryskin maintains $Thermo Fisher Scientific(TMO.US)$ with a buy rating, and adjusts the target price from $600 to $675.According to TipRanks data, the analyst has a